Clinical Trials on Rubeosis Iridis in Chile
Total 0 results
Nothing found
Sponsors and Collaborators
- Canadian Hemophilia Society
- IDRI Corporation
- Deutsche Arthrose-Hilfe
- Centre Hospitalier de Bastia
- Alfred Hospital Intensive Care Unit Australia
- University of Natural Resources and Life Sciences, Vienna, Austria
- Jikei University School of Medicine
- RINO ZUID
- InfraScan, Inc.
- Institute of Antibiotics, Huashan Hospital, Fudan University
- Shamir Optical Industry Ltd
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- Jiajie Chen
- Research Unit of General Practice, Odense
- Faculdade de Medicina da Universidade do Porto (FMUP)
- Delosis Limited
- Stefania Basili
- Donna Hammond, PhD
- Prof. Jürgen Kuschyk, M.D
- The First Affiliated Hospital of Air Force Medicial University
- View Full List
Medical Conditions
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma
- Sepsis and Coagulopathy
- Open Reduction and Internal Fixation
- Autosomal Dominant Hypocalcaemia
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- Robot-assisted Laparoscopic Prostatectomy Under General Anesthesia
- Ovarian Aging
- Neovascular Age-related Macular Degeneration(nAMD)
- Sensory Reconstruction of Digits
- Acute Myocardial Infarction, of Inferolateral Wall
- HIV Related Insulin Resistance
- Reduction, Weight
- Asian Consortium
- Insulin-Dependent Diabetes Mellitus
- Community-Acquired Staphylococcus Aureus
- Colonic Adenoma
- Surgery Induced Tissue Adhesions
- Subgluteal Sciatic Block
- Incompetence, Functional
- UP in Online Group Format
- View Full List
Drug Interventions
- Atorvastatin, 10mg, 20mg, 40mg
- Nanoliposomal Irinotecan
- Gemcitabine (mg/m²)
- Prucalopride
- Rosuvastatin calcium tablets
- Radioligand (11C)AZD2184
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
- INCB7839
- Hypertonic saline
- Arm 1 - GEH120714 (18F) Injection
- Propranolol Hydrochloride Extended Release Capsules 160 mg
- HLX23
- Chlorcyclizine HCl
- Moxifloxacin
- LIS 18 U
- Epoetin beta (NeoRecormon®)
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- Domperidone
- JR-141
- Sorafenib and OSI-906
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Belarus
- Contract Research Organizations in Burundi
- Contract Research Organizations in Finland
- Contract Research Organizations in Ireland
- Contract Research Organizations in Mexico
- Contract Research Organizations in Moldova
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Peru
- Contract Research Organizations in Philippines
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in Uruguay
- Contract Research Organizations in Venezuela
- CRO list by country